Facebook Linkedin Twitter
  • Home
  • News
    • COP Climate Change
    • COVID-19
    • Government
      • Finance
      • Workplace
    • Health & Social Care
      • Coronavirus (COVID-19)
      • Cancer Research
      • Diseases & Conditions
      • Mental Health
      • Pharma
      • Women’s Health
    • Environment
      • Circular Economy
      • Sustainable Development
    • Agriculture
    • Energy
    • Research & Innovation
    • Transport
    • Education
    • Technology
      • Artificial Intelligence
      • Digital Transformation
  • Publications
  • Academic Articles
  • Special Reports
    • Government
    • Health & Social Care
    • Environment
    • Agriculture
    • Energy
    • Research & Innovation
    • Transport
    • Education
    • Finance
    • HR & Training
    • Technology
  • Stakeholders
  • eBooks
    • Asia Analysis
    • North America Analysis
  • Subscribe
Search
Adjacent Open AccessOpen Access GovernmentOpen Access Government
  • Contact Us
  • About Us
  • Editors
  • Our Audience
  • Marketing Information Pack
  • Prestige Contributors
  • Testimonials
Adjacent Open AccessOpen Access GovernmentOpen Access Government
Linkedin
Twitter
Facebook
Instagram
  • Home
  • News
  • Publications
  • Academic Articles
  • Special Reports
  • Stakeholders
  • eBooks
  • Subscribe
  • Agriculture
  • Education
  • Energy
  • Environment
    • COP Climate Change
    • Circular Economy
    • Sustainable Development
  • Government
    • Finance
    • Workplace
  • Health
    • Cancer Research
    • Diseases & Conditions
    • Mental Health
    • Pharma
    • Women’s Health
    • COVID-19
  • Research
  • Technology
    • Artificial Intelligence
    • Digital Transformation
  • Transport
  • North America
  • Asia
Home Thomas J. Webster – UK Royal Society for Medicine

    Thomas J. Webster

    Entrepreneur
    UK Royal Society for Medicine

    Contributor's Details

    Email: websterthomas02@gmail.com

    Contributor's Articles

    • Figure 1: a) Nanotextured spinal implants now in over 30,000 humans with no cases of failure [2]. Such implants are being commercialized by Nanovis. b) Nanosensors now being used to detect the presence of bacteria, inflammatory cells, or bone-forming cells on implants. Such nanosensors can communicate to handheld devices and can respond in real-time to reverse adverse events. Such sensors have been implanted in sheep for up to 12 weeks showing the ability to promote bone growth.
      Opinion: What are the barriers to innovation in medicine?
    • Carcinoid tumors are a type of slow-growing cancer that can arise in several places throughout your body. Carcinoid tumors, which are one subset of tumors called neuroendocrine tumors, usually begin in the digestive tract (stomach, appendix, small intestine, colon, rectum) or in the lungs. Site: Ovary
      Are nanotextures enough to kill cancer cells?
    • Figure 1: Early research at Purdue University in the Webster lab that led to the formation of Nanovis, which now has over 3,000 FortiFixTM pedicle screws inserted in humans with no cases of implant failure, according to the Maude database. The industry standard of pedicle screw failures lies between 5 – 10% depending on the data assessed.
      Opinion: Do universities help or hurt innovation?
    • Soap bubbles on a pink background,Texture background.
      Artificial intelligence (AI) and biomaterials: A perfect BandAId™
    • Virus in dirty dust smoke flow in the air Covid- virus 3D rendering - nanotechnology
      How entrepreneurship and industry saved COVID fighting nanotechnology?
    Open Access Government

    Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

    Follow Us

    • LinkedIn
    • Twitter (X)
    • Facebook

    Resources

    • Stakeholders
    • Academic Articles
    • Publications
    • eBooks

    Quick Links

    • Contact Us
    • About Us
    • Our Editors
    • Our Audience
    • Prestige Contributors
    • Testimonials

    Legal & Marketing

    • Terms & Conditions
    • Privacy Policy
    • GDPR Info
    • GDPR Privacy Policy
    • Marketing Info Pack
    • Fee Schedule

    As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

    © Adjacent Digital Politics Ltd